HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Seik-Soon Khor Selected Research

Stevens-Johnson Syndrome (Lyell's Syndrome)

11/2019Identification of HLA-A*02:06:01 as the primary disease susceptibility HLA allele in cold medicine-related Stevens-Johnson syndrome with severe ocular complications by high-resolution NGS-based HLA typing.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Seik-Soon Khor Research Topics

Disease

9Narcolepsy
01/2023 - 01/2013
4Cataplexy
12/2018 - 01/2013
3Hepatitis B
03/2023 - 01/2018
3COVID-19
01/2023 - 01/2021
3Disorders of Excessive Somnolence (Hypersomnia)
12/2018 - 01/2013
2Infections
01/2023 - 01/2020
2Crohn Disease (Crohn's Disease)
01/2023 - 11/2018
2Hepatocellular Carcinoma (Hepatoma)
01/2023 - 01/2018
2Genetic Predisposition to Disease (Genetic Predisposition)
01/2018 - 01/2016
2Panic Disorder (Panic Attack)
01/2016 - 05/2015
2Sleep Wake Disorders
02/2015 - 01/2013
1Carcinogenesis
03/2023
1Liver Neoplasms (Liver Cancer)
03/2023
1Autoimmune Diseases (Autoimmune Disease)
01/2023
1Ulcerative Colitis
01/2023
1Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
01/2023
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2023
1Autoimmune Hepatitis
01/2023
1Brain Diseases (Brain Disorder)
01/2022
1Neoplasms (Cancer)
01/2022
1Seizures (Absence Seizure)
01/2022
1Viremia
01/2022
1Retinitis
01/2022
1Respiratory Insufficiency (Respiratory Failure)
01/2021
1Non-alcoholic Fatty Liver Disease
08/2020
1Stevens-Johnson Syndrome (Lyell's Syndrome)
11/2019
1Disease Susceptibility (Diathesis)
11/2019
1Hashimoto Disease (Thyroiditis, Hashimoto)
01/2019
1Graves Disease (Basedow Disease)
01/2019
1Thyroid Diseases (Thyroid Disease)
01/2019
1Moyamoya Disease (Moya-Moya Disease)
01/2019
1Hypersensitivity (Allergy)
01/2018
1Disease Progression
01/2018
1Nephrotic Syndrome (Syndrome, Nephrotic)
01/2018
1Idiopathic Hypersomnia
01/2015

Drug/Important Bio-Agent (IBA)

9HLA Antigens (Human Leukocyte Antigens)IBA
03/2023 - 02/2015
7HLA-DQB1 antigen (HLA DQB1)IBA
01/2022 - 01/2013
6HLA-DRB1 Chains (HLA DRB1)IBA
01/2023 - 05/2015
3HLA-A Antigens (HLA-A)IBA
03/2023 - 01/2018
3VaccinesIBA
01/2023 - 01/2018
3HLA-DR Antigens (HLA-DR)IBA
01/2023 - 01/2018
2HLA-DPB1 antigen (HLA DPB1)IBA
01/2023 - 01/2022
2OrexinsIBA
01/2023 - 05/2014
2HLA-DRB1*04 antigenIBA
01/2019 - 01/2018
1HLA-DQA1 antigen (HLA DQA1)IBA
01/2023
1tofacitinibIBA
01/2023
12-mercaptopurineIBA
01/2023
1vedolizumabIBA
01/2023
1Ustekinumab (CNTO 1275)FDA Link
01/2023
1COVID-19 VaccinesIBA
01/2023
1BNT162 VaccineIBA
01/2023
12019-nCoV Vaccine mRNA-1273IBA
01/2023
1Pyruvate Dehydrogenase Complex (Dehydrogenase Complex, Pyruvate)IBA
01/2023
1SteroidsIBA
01/2023
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2023
1Mesalamine (Mesalazine)FDA LinkGeneric
01/2023
1HLA-A24 AntigenIBA
01/2023
1Immunoglobulin G (IgG)IBA
04/2022
1Protein Sorting Signals (Signal Peptide)IBA
01/2022
1HLA-C Antigens (HLA-C)IBA
01/2021
1HLA-B*52:01 antigenIBA
01/2021
1Biomarkers (Surrogate Marker)IBA
01/2021
1HLA-DQ Antigens (HLA-DQ)IBA
08/2020
1MicroRNAs (MicroRNA)IBA
08/2020
1HLA-DR beta-ChainsIBA
08/2020
1myosin light chain 2IBA
08/2020
1HLA-B Antigens (HLA-B)IBA
08/2020
1Glycoproteins (Glycoprotein)IBA
08/2020
1Surface Antigens (Surface Antigen)IBA
01/2020
1Hepatitis B Surface Antigens (HBsAg)FDA Link
01/2020
1HLA-A*02:06:01 antigenIBA
11/2019
1Amino AcidsFDA Link
11/2018
1AntibodiesIBA
01/2018
1HLA-DQA2 antigenIBA
01/2018
1EpitopesIBA
01/2018
1Carnitine O-Palmitoyltransferase (Carnitine Palmitoyltransferase II)IBA
10/2016
1GTP-Binding Proteins (G-Protein)IBA
10/2016
1Purinergic Receptors (Receptors, Purine)IBA
10/2016
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
10/2016
1CC ChemokinesIBA
10/2015
1NeuropeptidesIBA
05/2014

Therapy/Procedure

1Therapeutics
01/2022
1Immunotherapy
01/2022